These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3796631)

  • 1. Anti-complementary action of polymorphic "solubility forms" of particulate inulin.
    Cooper PD; Carter M
    Mol Immunol; 1986 Aug; 23(8):895-901. PubMed ID: 3796631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties.
    Cooper PD; Steele EJ
    Vaccine; 1991 May; 9(5):351-7. PubMed ID: 1872020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.
    Cooper PD; Petrovsky N
    Glycobiology; 2011 May; 21(5):595-606. PubMed ID: 21147758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-melanoma activity of inulin in mice.
    Cooper PD; Carter M
    Mol Immunol; 1986 Aug; 23(8):903-8. PubMed ID: 3540619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical studies of complement activation.
    Garrigue MA; Muh JP; Bardos P
    Clin Chim Acta; 1983 Aug; 132(2):117-25. PubMed ID: 6616867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine adjuvants based on gamma inulin.
    Cooper PD
    Pharm Biotechnol; 1995; 6():559-80. PubMed ID: 7551236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
    Auteria A; Laghi Pasini F; Di Perri T
    Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adjuvanticity of gamma inulin.
    Cooper PD; Steele EJ
    Immunol Cell Biol; 1988; 66 ( Pt 5-6)():345-52. PubMed ID: 3265692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunochemical method for assessing the function of the alternative complement pathway.
    Yoshida K; Yukiyama Y; Hirose S
    Int Arch Allergy Appl Immunol; 1984; 75(2):173-8. PubMed ID: 6469388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative pathway fof bovine complement Immunochemical studies on factor B-like serum protein and its conversion product B gamma 2.
    Tabel H
    Can J Comp Med; 1981 Jul; 45(3):291-8. PubMed ID: 6176300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabbit CRP production after inulin injection.
    Horowitz J; Volanakis JE; Stroud RM
    Proc Soc Exp Biol Med; 1979 Feb; 160(2):222-5. PubMed ID: 419150
    [No Abstract]   [Full Text] [Related]  

  • 13. THE PHYSICAL PROPERTIES OF INULIN SOLUTIONS.
    PHELPS CF
    Biochem J; 1965 Apr; 95(1):41-7. PubMed ID: 14333566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice.
    Cooper PD; Sim RB
    Int J Cancer; 1984 May; 33(5):683-7. PubMed ID: 6724743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four new polymorphic forms of suplatast tosilate.
    Nagai K; Ushio T; Miura H; Nakamura T; Moribe K; Yamamoto K
    Int J Pharm; 2014 Jan; 460(1-2):83-91. PubMed ID: 24211359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a human alternative complement pathway inhibitor from hemolymph of larval fall armyworm (Spodoptera frugiperda).
    D'Cruz OJ; Day NK
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1426-33. PubMed ID: 6477568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activation of human serum complement with inulin and purification of SC5b-9].
    Zhou FL; Kan D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Aug; 13(4):293-7. PubMed ID: 1839526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fixation of C3b to pneumococcal cell wall polymers as a result of activation of the alternative complement pathway.
    Hummell DS; Berninger RW; Tomasz A; Winkelstein JA
    J Immunol; 1981 Oct; 127(4):1287-9. PubMed ID: 7024404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM; Gleich GJ
    J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.